Study on the drug release property of cholesteryl end-functionalized poly(ε-caprolactone) microspheres

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 77, Issue 1, 2006, Pages 39-46

  Yu, Lan ^a   Zhang, Hua ^a   Cheng, Si Xue ^a   Zhuo, Ren Xi ^a   Li, Hua ^b  

^a WUHAN UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Biomimetic; Degradation; Drug delivery release; Enzyme(s); Matrix; Polymerization

Indexed keywords

DEGRADATION; DRUG PRODUCTS; ENZYMES; MOLECULAR WEIGHT; POLYMERIZATION; SYNTHESIS (CHEMICAL);

DRUG DELIVERY/RELEASE; ENZYME(S); MATRIX;

POLYMERS;

BACTERIAL ENZYME; CHOLESTEROL DERIVATIVE; MICROSPHERE; POLYCAPROLACTONE; TRIACYLGLYCEROL LIPASE;

ARTICLE; BURKHOLDERIA CEPACIA; CHEMICAL STRUCTURE; DEGRADATION; DRUG HYDROLYSIS; DRUG RELEASE; EMULSION; MELTING POINT; MOLECULAR WEIGHT; POLYMERIZATION;

BIOCOMPATIBLE MATERIALS; BURKHOLDERIA CEPACIA; CHOLESTEROL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; LIPASE; MATERIALS TESTING; MICROSPHERES; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; POLYESTERS;

EID: 33645380137     PISSN: 00219304     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30395     Document Type: Article

References (23)

1. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475-2490.
2. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-ε- caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004;278:1-23.
3. Little SR, Lynn DM, Ge Q, Anderson DG, Puram SV, Chen J, Eisen HN, Langer R. Poly-β amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci USA 2004;101:9534-9539.
4. Lees-Haley PR, Williams CW. Neurotoxicity of chronic low-dose exposure to organic solvents: A skeptical review. J Clin Psychol 1997;53:699-712.
5. Berkland C, Kim K, Pack DW. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Control Release 2001;73:59-74.
6. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54(Suppl. 1):S131-S155.
7. Lang M, Wong RP, Chu CC. Synthesis and structural analysis of functionalized poly(ε-caprolactone)-based three-arm star polymers. J Polym Sci A: Polym Chem 2002;40:1127-1141.
8. Hwang JJ, Iyer SN, Li LS, Claussen R, Harrington DA, Stupp SI. Self-assembling biomaterials: Liquid crystal phases of cholesteryl oligo(L-lactic acid) and their interactions with cells. Proc Natl Acad Sci USA 2002;99:9662-9667.
9. Zhang L, Wang QR, Jiang XS, Cheng SX, Zhuo RX. Studies on functionalization of poly(ε-caprolactone) by cholesteryl moiety. J Biomater Sci Polym Ed., In press.
10. Mu L, Feng SS. Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Control Release 2001;76:239-254.
11. Philip VA, Mehta RC, Mazumder MK, DeLuca PP. Effect of surface treatment on the respirable fractions of PLGA microspheres formulated for dry powder inhalers. Int J Pharm 1997; 151:165-174.
12. Siepmann J, Göpferich A. Mathematical modeling of bioerodible, polymeric drug delivery systems. Adv Drug Deliv Rev 2001;48:229-247.
13. Zuleger S, Lippold BC. Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism. Int J Pharm 2001;217:139-152.
14. Reza MS, Quadir MA, Haider SS. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J Pharm Pharmaceut Sci 2003; 6:282-291.
15. Coviello T, Palleschi A, Grassi M, Matricardi P, Bocchinfuso G, Alhaique F. Scleroglucan: A versatile polysaccharide for modified drug delivery. Molecules 2005;10:6-33.
16. Ritger PL, Peppas NA. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable sevices in the form of slabs, spheres, cylinders or discs. J Control Release 1987;5:23-36.
17. Ritger PL, Peppas NA. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release 1987;5:37-42.
18. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001;48:139-157.
19. Liggins RT, Burt HM. Paclitaxel loaded poly(L-lactic acid) microspheres: Properties of microspheres made with low molecular weight polymers. Int J Pharm 2001;222:19-33.
20. Vandamme ThF, Mukendi JFN. Controlled release of levamisole from poly-(ε-caprolactone) matrices: III. Effects of molecular weight and polymer coating on drug release. Int J Pharm 1996;145:77-86.
21. Li S, Garreau H, Pauvert B, McGrath J, Toniolo A, Vert M. Enzymatic degradation of block copolymers prepared from ε-caprolactone and poly(ethylene glycol). Biomacromolecules 2002;3:525-530.
22. Chawla JS, Amiji MM. Biodegradable poly(ε-caprolactone) nanoparticles for tumortargeted delivery of tamoxifen. Int J Pharm 2002;249:127-138.
23. Sato H, Kiyono Y, Ohtani H, Tsuge S, Aoi H, Aoi K. Evaluation of biodegradation behavior of poly(ε-caprolactone) with controlled terminal structure by pyrolysis-gas chromatography and matrix-assisted laser desorption/ionization mass spectrometry. J Anal Appl Pyrolysis 2003;68-69:37-49.